Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans

Drahomira Sencakova, Neill R Graff Radford, Floyd Banard Willis, John A Lucas, Francine Parfitt, Ruth H. Cha, Peter C. O'Brien, Ronald Carl Petersen, Clifford R Jr. Jack

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Context: Imaging measurements may aid in the characterization and diagnosis of patients with Alzheimer disease (AD). Most research studies, however, have been performed on predominantly white study groups despite the fact that there may be biological differences in AD between African American and white patients. Objective: To measure hippocampal volume in African American patients with AD and to correlate these measurements with the presence of AD and neuropsychological test performance. Design: Survey study. Setting: Academic center. Participants: Fifty-four healthy African American subjects and 32 African American patients with AD were studied. Hippocampal volumes were measured in all subjects from magnetic resonance images using established methods. Main Outcome Measure: Correlations were assessed between hippocampal volume and demographic variables, clinical group membership, and neuropsychological performance. Results: The hippocampi of patients were atrophic with respect to those of healthy subjects (P<.01). Significant direct correlations were present between hippocampal volumes and performance on several different neuropsychological tests (r>0.5 and P<.01 for every test evaluated) when patients and healthy subjects were combined. Conclusions: Hippocampal atrophy is a feature of AD in African Americans as it is in white subjects. The neuropsychological-hippocampal volume correlations indicate that hippocampal volume measurements do represent a measure of the structural substrate of functional impairment in AD.

Original languageEnglish (US)
Pages (from-to)1593-1597
Number of pages5
JournalArchives of Neurology
Volume58
Issue number10
StatePublished - 2001

Fingerprint

African Americans
Atrophy
Alzheimer Disease
Healthy Volunteers
Neuropsychological Tests
Alzheimer's Disease
Hippocampus
Magnetic Resonance Spectroscopy
Demography
Outcome Assessment (Health Care)
Research

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans. / Sencakova, Drahomira; Graff Radford, Neill R; Willis, Floyd Banard; Lucas, John A; Parfitt, Francine; Cha, Ruth H.; O'Brien, Peter C.; Petersen, Ronald Carl; Jack, Clifford R Jr.

In: Archives of Neurology, Vol. 58, No. 10, 2001, p. 1593-1597.

Research output: Contribution to journalArticle

@article{da3215e6bfbb4d35a454c793e1124730,
title = "Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans",
abstract = "Context: Imaging measurements may aid in the characterization and diagnosis of patients with Alzheimer disease (AD). Most research studies, however, have been performed on predominantly white study groups despite the fact that there may be biological differences in AD between African American and white patients. Objective: To measure hippocampal volume in African American patients with AD and to correlate these measurements with the presence of AD and neuropsychological test performance. Design: Survey study. Setting: Academic center. Participants: Fifty-four healthy African American subjects and 32 African American patients with AD were studied. Hippocampal volumes were measured in all subjects from magnetic resonance images using established methods. Main Outcome Measure: Correlations were assessed between hippocampal volume and demographic variables, clinical group membership, and neuropsychological performance. Results: The hippocampi of patients were atrophic with respect to those of healthy subjects (P<.01). Significant direct correlations were present between hippocampal volumes and performance on several different neuropsychological tests (r>0.5 and P<.01 for every test evaluated) when patients and healthy subjects were combined. Conclusions: Hippocampal atrophy is a feature of AD in African Americans as it is in white subjects. The neuropsychological-hippocampal volume correlations indicate that hippocampal volume measurements do represent a measure of the structural substrate of functional impairment in AD.",
author = "Drahomira Sencakova and {Graff Radford}, {Neill R} and Willis, {Floyd Banard} and Lucas, {John A} and Francine Parfitt and Cha, {Ruth H.} and O'Brien, {Peter C.} and Petersen, {Ronald Carl} and Jack, {Clifford R Jr.}",
year = "2001",
language = "English (US)",
volume = "58",
pages = "1593--1597",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans

AU - Sencakova, Drahomira

AU - Graff Radford, Neill R

AU - Willis, Floyd Banard

AU - Lucas, John A

AU - Parfitt, Francine

AU - Cha, Ruth H.

AU - O'Brien, Peter C.

AU - Petersen, Ronald Carl

AU - Jack, Clifford R Jr.

PY - 2001

Y1 - 2001

N2 - Context: Imaging measurements may aid in the characterization and diagnosis of patients with Alzheimer disease (AD). Most research studies, however, have been performed on predominantly white study groups despite the fact that there may be biological differences in AD between African American and white patients. Objective: To measure hippocampal volume in African American patients with AD and to correlate these measurements with the presence of AD and neuropsychological test performance. Design: Survey study. Setting: Academic center. Participants: Fifty-four healthy African American subjects and 32 African American patients with AD were studied. Hippocampal volumes were measured in all subjects from magnetic resonance images using established methods. Main Outcome Measure: Correlations were assessed between hippocampal volume and demographic variables, clinical group membership, and neuropsychological performance. Results: The hippocampi of patients were atrophic with respect to those of healthy subjects (P<.01). Significant direct correlations were present between hippocampal volumes and performance on several different neuropsychological tests (r>0.5 and P<.01 for every test evaluated) when patients and healthy subjects were combined. Conclusions: Hippocampal atrophy is a feature of AD in African Americans as it is in white subjects. The neuropsychological-hippocampal volume correlations indicate that hippocampal volume measurements do represent a measure of the structural substrate of functional impairment in AD.

AB - Context: Imaging measurements may aid in the characterization and diagnosis of patients with Alzheimer disease (AD). Most research studies, however, have been performed on predominantly white study groups despite the fact that there may be biological differences in AD between African American and white patients. Objective: To measure hippocampal volume in African American patients with AD and to correlate these measurements with the presence of AD and neuropsychological test performance. Design: Survey study. Setting: Academic center. Participants: Fifty-four healthy African American subjects and 32 African American patients with AD were studied. Hippocampal volumes were measured in all subjects from magnetic resonance images using established methods. Main Outcome Measure: Correlations were assessed between hippocampal volume and demographic variables, clinical group membership, and neuropsychological performance. Results: The hippocampi of patients were atrophic with respect to those of healthy subjects (P<.01). Significant direct correlations were present between hippocampal volumes and performance on several different neuropsychological tests (r>0.5 and P<.01 for every test evaluated) when patients and healthy subjects were combined. Conclusions: Hippocampal atrophy is a feature of AD in African Americans as it is in white subjects. The neuropsychological-hippocampal volume correlations indicate that hippocampal volume measurements do represent a measure of the structural substrate of functional impairment in AD.

UR - http://www.scopus.com/inward/record.url?scp=0034793411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034793411&partnerID=8YFLogxK

M3 - Article

C2 - 11594917

AN - SCOPUS:0034793411

VL - 58

SP - 1593

EP - 1597

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 10

ER -